Observational × Carcinoma, Ovarian Epithelial × Gynecologic × Clear all Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study
Completed
51 enrolled 28 charts
Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers
Completed
119 enrolled
GREAT
Completed
1,500 enrolled
IMPrOVE
Recruiting
300 enrolled
Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer
Completed
10 enrolled
IOSI-GYNE-001
Recruiting
74 enrolled
ORACLE
Recruiting
2,020 enrolled
COOC - REMO
Active not recruiting
200 enrolled
START
Terminated
10 enrolled
ORACLE
Recruiting
168 enrolled
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
Withdrawn
REMISSION
Recruiting
1,500 enrolled
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Recruiting
6,000 enrolled
PARPi and Ovarian Cancer Survival
Not yet recruiting
6,000 enrolled
PRODIGYN
Recruiting
120 enrolled
Mupet
Active not recruiting
150 enrolled
Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian Cancer
Recruiting
70 enrolled
INFLUENCE
Active not recruiting
70 enrolled
EXCYTE-1
Terminated
13 enrolled
CUKUROVA
Recruiting
130 enrolled
Research on Nutritional Risk Indexes and Inflammatory Indicators in Postoperative Complications and Prognosis of Epithelial Ovarian Cancer Patients
Completed
1,108 enrolled
Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test
Completed
1,352 enrolled
To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian Cancer
Not yet recruiting
100 enrolled
Predicting the Risk of Ovarian Cancer Recurrence Using Circulating Tumor DNA to Assess Residual Disease
Unknown
45 enrolled
SUROVA
Unknown
5,000 enrolled
Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective Study
Unknown
1,000 enrolled
A Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal Cancer
Not yet recruiting
60 enrolled
Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence
Unknown
20 enrolled
OutCoME
Unknown
75 enrolled
ctDNA Methylation for Epithelial Ovarian Cancer
Recruiting
5,000 enrolled
ctDNA Methylation for Detecting Ovarian Cancer
Recruiting
1,400 enrolled
Ovarian Tumor Biopsies to Study Response to Treatments
Completed
5 enrolled
Chromosomal Instability in Ovarian Cancer
Unknown
300 enrolled
HRD and Resistance to PAPPi in EOC Patients
Unknown
400 enrolled
A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer
Completed
240 enrolled
Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer
Completed
316 enrolled
RENI-1
Unknown
300 enrolled
PaVaClO
Completed
550 enrolled
A Training Set for the HRD Model in EOC
Unknown
200 enrolled
Genetic Mutation in Epithelial Ovarian Cancer
Unknown
500 enrolled
Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer
Unknown
1,300 enrolled
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Terminated
150 enrolled
E-MOSAIC Electronic Tool to Monitor Symptoms
Completed
264 enrolled
Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants
Completed
581 enrolled
A Genomic Analysis of Evolution of Epithelia Ovarian Tumors
Unknown
40 enrolled
A Multi-omics Study of Epithelial Ovarian Cancer
Unknown
80 enrolled
Inherited Susceptible Genes Among Epithelial Ovarian Cancer
Unknown
1,000 enrolled
Ovaire01
Unknown
376 enrolled
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Terminated
1,000 enrolled
Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer
Completed
525 enrolled